Sole provider of FDA-approved Automated Breast Ultrasound screening, helping physicians look differently at dense breast tissue.
Mammography may miss over 1/3 of cancers in dense breasts. The InveniaTM ABUS (Automated Breast Ultrasound System) is a comfortable, non-ionizing alternative to other supplemental screening options for women with dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 35.7 percent over mammography alone.
Why is Invenia ABUS screening needed?
Approximately 40% of American women have dense breasts. Having dense breasts can increase a woman’s risk to develop cancer by 4-6 times.4 Mammography may miss cancers in dense breasts, Invenia ABUS has been proven to help clinicians find 35.7 percent more cancers
after a normal or benign mammographic finding.
What are the steps in an Invenia ABUS exam?
The Invenia ABUS acquisition process uses 3D ultrasound technology to comfortably and quickly image women with dense breast tissue. Each exam takes approximately 15 minutes.